Geron Corporation (GERN Quick QuoteGERN - Free Report) was a big mover last session, as the company saw its shares rise over 7% on the day. The move came on solid volume with far more shares changing hands than in a normal session. This continues the recent uptrend of the company, as the stock is now up over 22% in the past one-month time frame.

The company has seen one positive estimate revision in the last 30 days, while the Zacks Consensus Estimate remained unchanged. Friday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future. 

Currently, Geron Corporation carries a Zacks Rank #2 (Buy).

Geron Corporation Price

 

Geron Corporation Price | Geron Corporation Quote

Another top-ranked stock in the same industry is Akari Therapeutics, Plc (AKTX Quick QuoteAKTX - Free Report) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is GERN going up? Or down? Predict to see what others think: Up or Down

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course. Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>